How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?

Carmel Armon

How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?

Neurology

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	3-14
Number of pages	12
Journal	Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Volume	1
Issue number	1
State	Published - Dec 1999

ASJC Scopus Subject Areas

Clinical Neurology

Keywords

Amyotrophic lateral sclerosis
Measures of disease progression
Outcome measures
Quality of life
Treatment

OpenUrl availability

Full text

Cite this

@article{0f1faac5d5f14a86a9660a1b0b85c2c2,

title = "How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?",

keywords = "Amyotrophic lateral sclerosis, Measures of disease progression, Outcome measures, Quality of life, Treatment",

author = "Carmel Armon",

year = "1999",

month = dec,

language = "English",

volume = "1",

pages = "3--14",

journal = "Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders",